Jiangsu Biostronger Technology Co.,Ltd


HGH, Peptides, IGF-1 LR3, EGF, VEGF, Steroids And SARMs powder, Etc.

About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsWeight Loss Growth Hormone

CAS 616202-92-7 Weight Loss Growth Hormone Drug Raw Powder Lorcaserin Powder

I'm Online Chat Now
Just completed an order with Peter and his service is A+++. I have posted it elsewhere on the board. I did a gh serum test with his gh and it comes back more 30, crazy high score for 10iu.

—— Ricky Rodrig from USA

Was and am VERY, VERY impressed with Peter. Superb communication and overall customer service!! A+++++. will definitely be doing business with you.

—— Trevor Maki from UK

CAS 616202-92-7 Weight Loss Growth Hormone Drug Raw Powder Lorcaserin Powder

CAS 616202-92-7 Weight Loss Growth Hormone Drug Raw Powder Lorcaserin Powder
CAS 616202-92-7 Weight Loss Growth Hormone Drug Raw Powder Lorcaserin Powder

Large Image :  CAS 616202-92-7 Weight Loss Growth Hormone Drug Raw Powder Lorcaserin Powder Get Best Price

Product Details:

Place of Origin: China
Brand Name: SGH
Certification: GMP, ISO9001,BRC,KOSHER
Model Number: 616202-92-7

Payment & Shipping Terms:

Minimum Order Quantity: 10g
Price: Negotiation
Packaging Details: Discreet package or foiled bag or pack as customer's request
Payment Terms: T/T, Western Union, MoneyGram, Bitcoin
Supply Ability: 100kg/Month
Detailed Product Description
CAS NO: 616202-92-7 Synonyms: Lorcaserin
Form: Powder Usage: Loss Weight
Color: White Storage: -20C
High Light:

hgh weight loss


lose fat steroids

CAS 616202-92-7 Weight Loss Growth Hormone Drug Raw Powder Lorcaserin Powder


Product Name:
Product Name: Lorcaserin
Synonyms: (R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;Apd 356;Apd356;Apd-
CAS: 616202-92-7
MF: C11H14ClN
MW: 195.692
EINECS: 1308068-626-2
Product Categories: Amines;Aromatics;Chiral Reagents;Heterocycles;Intermediates & Fine
Boiling point 288°C
density 1.075
Fp 128 o°C
storage temp. -20°C Freezer
Appearance: White Powder


Appearance Off-white or white powder Conforms
Identification HPLC,NMR;LC-MS Conforms
Related substances Individual impurity≤0.5% 0.09%
Total impurities≤1.0% 0.20%
Loss on drying ≤0.5% 0.3%
Residue on ignition ≤0.1% 0.04%
Heavy metals ≤10ppm Conforms
Assay ≥98.0 % 99.1%

Weight loss drugs:
Lorcaserin is a new drug for the treatment of obesity , belonging to oral potent selective
serotonin 2C receptor agonists, lorcaserin hydrochloride is successfully developed by the
US company Arena, on June 27, 2012 by the US FDA it is approved for marketing, as adjuvant
therapy for obesity or merge with at least one weight-related complications in overweight
adults in low-calorie diet and exercise basis . Clinical studies show that the drug can
reduce weight of obesity and overweight patients ,it can improve obesity-related metabolic
parameters, and it is well tolerated. Lorcaserin affinity for the 5-HT2c 100 times higher
than the 5-HT2B (valvular heart disease risk) ,it has good safety,it is the first FDA-
approved weight-loss drug after 1999 . In a year of Lorcaserin treatment, the average
weight loss ranges from 3 to 3.7 percent.

Drug Interactions:
Due to the theoretical possibility of the mechanism of lorcaserin and serotonin syndrome,
when lorcaserin is used in combination with the serotonergic neurotransmitter system drugs,
extreme caution should be paid, including triptans monoamine oxidase inhibitor agent
selective serotonin reuptake inhibitor selective serotonin and norepinephrine reuptake
inhibitors, tricyclic antidepressants bupropion dextromethorphan, lithium tramadol and St.
John's wort , etc. In addition, when the present product with CYP2D6 substrates when
combined with the need to be cautious, because the product can increase the exposure of
these drugs.

Lorcaserin has good tolerability and safety, lorcaserin is used in non-diabetic patients,
the most common adverse reactions are headache, dizziness, fatigue, nausea, dry mouth and
constipation. This product is used in patients with diabetes, common adverse reactions are
headache, back pain, cough, low blood sugar and fatigue.studies have found that lorcaserin
and placebo are Similar in the proportion of serious adverse reactions, lorcaserin does not
increase the incidence of valvular heart disease. After lorcaserin treatment , the
incidence of depression is lower , the research shows that the proportion of depression led
by lorcaserin 10mgbid, 10mgqd and placebo are 1.9%, 1.1% and 1.8%, emotional low incidence
rates are 0.6%, 0.9% and 0.9%, the proportion of suicidal thoughts are 0.9%, 0.6% and 0.7%
.the product is pregnancy X-class , pregnant women are disabled; whether this product is
secreted by milk is unknown, breast-feeding women need to weigh on the use of the drug;
this product is not recommended for children.




Related products:

Peptides Proteins Steroids Powder
GHRP-2 IGF-1 LR3 17a-Methyl-1-Testosterone
GHRP-6 IGF-1 LR3 Anastrozole (Arimidex)
CJC-1295 with DAC IGF-1 DES Boldenone
CJC-1295 NO DAC Follistatin Boldenone undecylenate (EQ)
HGH176-191 HGH Clomiphene Citrate(Clomid)
PT-141 HCG Tamoxifen Citrate
Thymosin β4 (TB500) EPO Nolvadex
Ipamorelin HMG Sildenafil(Viagra)
Melanotan-II (MT-II)   Tadalafil (Cialis)
Melanotan-I (MT-I) SARM Letrozole (Femara)
PEG-MGF MK-2866 (Ostarine) Exemestane(Aromasin)
MGF Andarine (S4) Formestane
Hexarelin GW-501516 (Cardarine) Mesterolone(Proviron)
Sermorelin S-23 Methandrostenolone (Dianabol)
Triptorelin LGD-4033 (Ligandrol) Methenolone Acetate
Gonadoreline LGD-3303 Methenolone Enanthate
Selank MK-677 (Ibutamoren) Turinabol
BPC-157 SR9009 Nandrolone decanoate
Oxytocin SR9011 Nandrolone phenylpropionate
DSIP RAD140 Oxymetholone (Anadrol)
GHRH YK-11 Stanozolol Coarse (Winstrol)
Tesamorelin Aicar Stanozolol Micronized (Winstrol)
Epitalon Laxogenin Oxandrolone (Anavar)




Contact Details
Jiangsu Biostronger Technology Co.,Ltd

Contact Person: sales

Send your inquiry directly to us